Brief: Eagle Pharmaceuticals Reiterates 2023 Adjusted Non-GAAP EBITDA And Adjusted Non-GAAP E¹ Guidance
17/08/2023 12:23
Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS REITERATES 2023 ADJUSTED NON-GAAP
EBITDA
AND ADJUSTED NON-GAAP E¹ GUIDANCE
Source text for Eikon: ID:nGNX9Wf7j4
Further company coverage: EGRX.O
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq